1. IGF-I/EGF and E2 signaling crosstalk through IGF-IR conduit point affects breast cancer cell adhesion
   Kallirroi Voudouri et al, 2016, Matrix Biology CrossRef
2. Lactate is a potential promoter of tamoxifen resistance in MCF7 cells
   Valentina Rossi et al, 2022, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
3. PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells
   Koichi Ito et al, 2017, npj Breast Cancer CrossRef
4. Inhibition of platelet-derived growth factor C and their receptors additionally increases doxorubicin effects in triple-negative breast cancer cells
   Sangmin Kim et al, 2021, European Journal of Pharmacology CrossRef
5. Prognostic and clinicopathological value of Slug protein expression in breast cancer: a systematic review and meta-analysis
   Zhihao Zhang et al, 2022, World Journal of Surgical Oncology CrossRef
6. Challenges of Endocrine Therapy in Breast Cancer
   Sepideh Mansouri et al, 2017, Cancer Genetics and Psychotherapy CrossRef
7. Relation of EGFR/PI3K/AKT signaling components with tamoxifen efficacy in patients with estrogen-dependent breast cancer
   T. A. Dronova et al, 2018, Advances in molecular oncology CrossRef
8. Upregulation of SOX11 enhances tamoxifen resistance and promotes epithelial‐to‐mesenchymal transition via slug in MCF‐7 breast cancer cells
   Yingsheng Xiao et al, 2020, Journal of Cellular Physiology CrossRef
9. Bioinformatic analysis reveals the molecular targets of tangeretin in overcoming the resistance of breast cancer to tamoxifen
   Adam Hermawan et al, 2020, Gene Reports CrossRef
10. MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells
    SANGMIN KIM et al, 2016, Oncology Reports CrossRef
11. Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells
    Daeun You et al, 2017, BMB Reports CrossRef
12. Roles of Small GTPases in Acquired Tamoxifen Resistance in MCF-7 Cells Revealed by Targeted, Quantitative Proteomic Analysis
    Ming Huang et al, 2018, Analytical Chemistry CrossRef
13. Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer
    Jingwei Yao et al, 2020, Frontiers in Pharmacology CrossRef
14. Expression of SATB1 and E-cad in tissues of patients with endometrial carcinoma and the relationship with clinicopathological features
    Yanli Feng et al, 2018, Experimental and Therapeutic Medicine CrossRef
15. Impact of estrogen receptor α on the tamoxifen response and prognosis in luminal-A-like and luminal-B-like breast cancer
    Nataliya Babyshkina et al, 2019, Clinical and Experimental Medicine CrossRef
16. Tamoxifen: The Past, Present, and Future of a Previous Orphan Drug
    Ghadier Matariek et al, 2022, European Journal of Medical and Health Sciences CrossRef